In mild cytokine storm models (1× or lower dose), monotherapy for TNF-α, IL-6, or IL-4Rα depletion was effective in reducing common cold–induced albuminuria, suggesting a potential therapeutic approach to prevent MCD or FSGS relapse. The gene discussed is TNF; the disease is focal segmental glomerulosclerosis.